US Map / Iowa
State IA

Clinical Trials in Iowa

Iowa is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Iowa and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 107 actively recruiting studies with Iowa sites out of 107 registered in total. The busiest research areas in Iowa are Breast Cancer, Metastatic Breast Cancer, Stage IVB Prostate Cancer AJCC v8. Leading sponsors running trials in the state include National Cancer Institute (NCI), AstraZeneca, Alliance for Clinical Trials in Oncology. By stage, Iowa trials break down as Phase 1 (14), Phase 2 (29), Phase 3 (36), Phase 4 (4).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
107
Recruiting Now
107
← Back to US Map
Top Conditions in Iowa
Breast Cancer (4)Metastatic Breast Cancer (3)Stage IVB Prostate Cancer AJCC v8 (2)Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (2)Locally Recurrent Head and Neck Squamous Cell Carcinoma (2)Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma (2)Locally Recurrent Laryngeal Squamous Cell Carcinoma (2)Locally Recurrent Oral Cavity Squamous Cell Carcinoma (2)Locally Recurrent Oropharyngeal Squamous Cell Carcinoma (2)Stage III Laryngeal Cancer AJCC v8 (2)Stage III Lip and Oral Cavity Cancer AJCC v8 (2)Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (2)

Frequently Asked Questions — Clinical Trials in Iowa

How many clinical trials are currently recruiting in Iowa?
ClinicalMetric currently tracks 107 actively recruiting clinical trials with at least one location in Iowa. The total number of registered studies—including active but not currently enrolling trials—is 107. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Iowa?
Iowa hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Metastatic Breast Cancer, Stage IVB Prostate Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Iowa serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Iowa?
To join a clinical trial in Iowa, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Iowa maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Iowa

NCT05564390 Phase 2
Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatmen...
Condition
Acute Myeloid Leukemia
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06417762 N/A
Recruiting
Dime La VerDAD: Verify, Debunk, and Disseminate
Condition
Influenza
Enrollment
1,400 pts
Location
United States
Sponsor
University of Chicago
View Trial →
NCT06029491 N/A
Recruiting
The Pivotal Study of RapidPulseTM Aspiration System
Condition
Acute Ischemic Stroke
Enrollment
170 pts
Location
United States, France, Spain
Sponsor
RapidPulse, Inc
View Trial →
NCT05774951 Phase 3
Recruiting
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years ...
Condition
Breast Cancer, Early Breast Cancer
Enrollment
4,300 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT01810913 Phase 2, Phase 3
Recruiting
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizum...
Condition
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma
Enrollment
613 pts
Location
United States, Canada, Hong Kong
Sponsor
National Cancer Institute (NCI
View Trial →
NCT03550391 Phase 3
Recruiting
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radioth...
Condition
Brain Metastases
Enrollment
206 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT07187115 N/A
Recruiting
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping ...
Condition
Atrial Fibrillation (AF)
Enrollment
699 pts
Location
United States, Belgium, France
Sponsor
Boston Scientific Corporation
View Trial →
NCT05950464 Phase 1
Recruiting
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the...
Condition
Recurrent Endometrial Carcinoma
Enrollment
65 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05183035 Phase 3
Recruiting
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Condition
Acute Myeloid Leukemia
Enrollment
130 pts
Location
United States, Australia, Austria
Sponsor
PedAL BCU, LLC
View Trial →
NCT04251052 N/A
Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations t...
Condition
Ovarian Carcinoma
Enrollment
1,956 pts
Location
United States, Canada, South Korea
Sponsor
NRG Oncology
View Trial →
NCT05820672 N/A
Recruiting
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With...
Condition
Growth Hormone Deficiency
Enrollment
900 pts
Location
United States
Sponsor
Ascendis Pharma Endocrinology
View Trial →
NCT05235165 Phase 3
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients ...
Condition
Metastatic Malignant Neoplasm in the Lung
Enrollment
62 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT02981628 Phase 2
Recruiting
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma...
Condition
Recurrent B Acute Lymphoblastic Leukemia
Enrollment
80 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
View Trial →
NCT06958536 Phase 2
Recruiting
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's...
Condition
Crohn's Disease
Enrollment
99 pts
Location
United States, Australia, Belgium
Sponsor
Sanofi
View Trial →
NCT06898671 N/A
Recruiting
Language Outcomes, Mechanisms, and Trajectories in Adults With and Without Devel...
Condition
Developmental Language Disorder
Enrollment
400 pts
Location
United States
Sponsor
University of Iowa
View Trial →
NCT06974357 N/A
Recruiting
Evaluation of Genetic Abnormalities Amongst Calcium Phosphate Stone Formers
Condition
Nephrolithiasis
Enrollment
15 pts
Location
United States
Sponsor
Ryan L Steinberg
View Trial →
NCT06418204 N/A
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...
Condition
Breast Carcinoma
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
View Trial →
NCT07406633 Phase 2
Recruiting
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIS...
Condition
GIST - Gastrointestinal Stromal Tumor
Enrollment
46 pts
Location
United States
Sponsor
Kumquat Biosciences Inc.
View Trial →
NCT06806033 Phase 2
Recruiting
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile fo...
Condition
B-Cell Non-Hodgkins Lymphoma
Enrollment
100 pts
Location
United States, Australia, Canada
Sponsor
Hoffmann-La Roche
View Trial →
NCT06712316 Phase 2, Phase 3
Recruiting
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherap...
Condition
Non-small Cell Lung Cancer
Enrollment
1,260 pts
Location
United States, Australia, Belgium
Sponsor
BioNTech SE
View Trial →
NCT05685433 N/A
Recruiting
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Eval...
Condition
Overactive Bladder
Enrollment
200 pts
Location
United States
Sponsor
Valencia Technologies Corporat
View Trial →
NCT06932263 Phase 2
Recruiting
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults ...
Condition
Asthma
Enrollment
540 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
View Trial →
NCT07296484 Phase 2
Recruiting
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Condition
Type 2 Diabetes
Enrollment
1,500 pts
Location
United States
Sponsor
Sparrow Pharmaceuticals
View Trial →
NCT05939414 Phase 3
Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Obse...
Condition
Oligometastatic Prostate Cancer (OMPC)
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06632977 Phase 2
Recruiting
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Condition
Castration-Resistant Prostate Carcinoma
Enrollment
474 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
Page 2 of 5 — 107 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology